よむ、つかう、まなぶ。
04資料1-2 森野委員提出資料（成人用肺炎球菌ワクチンファクトシート追補版） (35 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_76211.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第36回 9／17）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
72.
Sharomi O, Oidtman RJ, Lang JC, et al. Health impact and cost-effectiveness analysis of introducing
a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults
≥65 years of age in Denmark. Expert Rev Pharmacoecon Outcomes Res 2026; 26(6): 757–67.
73.
Government of Canada. Recommendations on the use of pneumococcal vaccines in adults, including
PNEU-C-21. 2025/10/30. https://www.canada.ca/en/public-health/services/publications/vaccinesimmunization/national-advisory-committee-immunization-statement-recommendations-use-pneumococcalvaccines-adults-pneu-c-21.html (accessed 2026/7/31).
74.
Centers for Disease Control and Prevention. Summary of Risk-based Pneumococcal Vaccination
Recommendations. 2026/5/8 2026. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/riskindications.html (accessed 2026/7/31).
75.
Institut National de Sante Publique du Quebec. Stratégie de prévention des infections
pneumococciques au Québec avec l’introduction des nouveaux vaccins conjugués. 2025/3.
https://www.inspq.qc.ca/sites/default/files/publications/3661-infections-pneumococciques-QC-vaccinsconjugues.pdf (accessed 2026/7/31).
76.
Public Health Ontario. Updated Recommendations for Pneumococcal Immunization in Adults,
Including the Use of a 21-valent Pneumococcal Conjugate Vaccine. 2025/7.
https://www.publichealthontario.ca/-/media/Documents/O/25/oiac-recommendations-pneumococcalimmunization-adultspcv21.pdf?rev=28c9ef9e60c94114ae4d2612138078c5&sc_lang=en&hash=23E2CDBF3225ECF86C9D1D2D5
61529C4 (accessed 2026/7/31).
77.
Centers for Disease Control and Prevention. Pneumococcal Vaccine Recommendations. 2026/2/25
2026. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html (accessed 2026/7/31).
78.
Government of Canada. Pneumococcal vaccines: Canadian Immunization Guide. 2025/9/10.
https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guidepart-4-active-vaccines/page-16-pneumococcal-vaccine.html (accessed 2026/7/31).
79.
UK Health Security Agency. Green book Chapter 25: Pneumococcal. 2025/6/12.
https://assets.publishing.service.gov.uk/media/684b1fbc1c8d5c94e201abae/Green_Book__Chapter_25_pneu
mococcal_12_6_25.pdf (accessed 2026/7/31).
80.
UK Health Security Agency. Guidance Pneumococcal vaccination for older adults and for individuals
in a clinical risk group: Information for healthcare practitioners. 2026/4/13 2026.
https://www.gov.uk/government/publications/pneumococcal-vaccination-for-older-adults-and-forindividuals-in-a-clinical-risk-group-information-for-healthcare-practitioners/pneumococcal-vaccination-forolder-adults-and-for-individuals-in-a-clinical-risk-group-information-for-healthcare-practitioners (accessed
2026/7/31).
81.
European Centre for Disease Prevention and Control. Vaccine Scheduler Pneumococcal Disease:
Recommended vaccinations. https://vaccineschedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=-1
(accessed 2026/7/31).
35
Sharomi O, Oidtman RJ, Lang JC, et al. Health impact and cost-effectiveness analysis of introducing
a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults
≥65 years of age in Denmark. Expert Rev Pharmacoecon Outcomes Res 2026; 26(6): 757–67.
73.
Government of Canada. Recommendations on the use of pneumococcal vaccines in adults, including
PNEU-C-21. 2025/10/30. https://www.canada.ca/en/public-health/services/publications/vaccinesimmunization/national-advisory-committee-immunization-statement-recommendations-use-pneumococcalvaccines-adults-pneu-c-21.html (accessed 2026/7/31).
74.
Centers for Disease Control and Prevention. Summary of Risk-based Pneumococcal Vaccination
Recommendations. 2026/5/8 2026. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/riskindications.html (accessed 2026/7/31).
75.
Institut National de Sante Publique du Quebec. Stratégie de prévention des infections
pneumococciques au Québec avec l’introduction des nouveaux vaccins conjugués. 2025/3.
https://www.inspq.qc.ca/sites/default/files/publications/3661-infections-pneumococciques-QC-vaccinsconjugues.pdf (accessed 2026/7/31).
76.
Public Health Ontario. Updated Recommendations for Pneumococcal Immunization in Adults,
Including the Use of a 21-valent Pneumococcal Conjugate Vaccine. 2025/7.
https://www.publichealthontario.ca/-/media/Documents/O/25/oiac-recommendations-pneumococcalimmunization-adultspcv21.pdf?rev=28c9ef9e60c94114ae4d2612138078c5&sc_lang=en&hash=23E2CDBF3225ECF86C9D1D2D5
61529C4 (accessed 2026/7/31).
77.
Centers for Disease Control and Prevention. Pneumococcal Vaccine Recommendations. 2026/2/25
2026. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html (accessed 2026/7/31).
78.
Government of Canada. Pneumococcal vaccines: Canadian Immunization Guide. 2025/9/10.
https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guidepart-4-active-vaccines/page-16-pneumococcal-vaccine.html (accessed 2026/7/31).
79.
UK Health Security Agency. Green book Chapter 25: Pneumococcal. 2025/6/12.
https://assets.publishing.service.gov.uk/media/684b1fbc1c8d5c94e201abae/Green_Book__Chapter_25_pneu
mococcal_12_6_25.pdf (accessed 2026/7/31).
80.
UK Health Security Agency. Guidance Pneumococcal vaccination for older adults and for individuals
in a clinical risk group: Information for healthcare practitioners. 2026/4/13 2026.
https://www.gov.uk/government/publications/pneumococcal-vaccination-for-older-adults-and-forindividuals-in-a-clinical-risk-group-information-for-healthcare-practitioners/pneumococcal-vaccination-forolder-adults-and-for-individuals-in-a-clinical-risk-group-information-for-healthcare-practitioners (accessed
2026/7/31).
81.
European Centre for Disease Prevention and Control. Vaccine Scheduler Pneumococcal Disease:
Recommended vaccinations. https://vaccineschedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=-1
(accessed 2026/7/31).
35